Who owns IP

Enjoy these stories?

Climate change is killing us — in more ways than one

We’ve all heard about climate change’s effect on our planet, but what about its catastrophic impact on human health?

Many elections, many consequences

With a vast number of citizens around the world voting for leaders and legislatures this year, much will depend on their trust in the electoral

Time to defend science under attack

In an age of “alternative facts” and conspiracy theories, protecting trust in science is crucial.

Who owns IP

Global perspectives on the state of intellectual property

(more…)

Keeping traditional knowledge free

Recent work has strengthened the intellectual property rights ecosystem to protect traditional knowledge from commercial patents.

(more…)

China’s Big Pharma bet could change the IP game

China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.

(more…)

Less talk, more action needed to reform IP for all

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

(more…)

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

(more…)

You say potato, I say property rights

A battle between PepsiCo and Indian farmers highlights the gap between international trade law and countries seeking to protect their farmers’ seed rights.

(more…)

IP hinders access to affordable drugs for all

Changes to a global agreement allowing compulsory licensing of COVID-19 vaccines do nothing to improve access in developing economies. Cost is still a barrier.

(more…)

The public deserves a return on the medicines governments support

Public money directly and indirectly supports pharmaceutical innovation. Governments need to ensure the public gets a fair return on its investment.

(more…)

About Us

More

Stay up to date

Enjoy these stories?

Climate change is killing us — in more ways than one

Many elections, many consequences

Time to defend science under attack

Who owns IP

Keeping traditional knowledge free

China’s Big Pharma bet could change the IP game

Less talk, more action needed to reform IP for all

Patent waiver is no silver bullet, even during COVID-19

You say potato, I say property rights

IP hinders access to affordable drugs for all

The public deserves a return on the medicines governments support

Enjoy these stories?

About

Our Policies

For journalists & newsrooms

For researchers

For non-media organisations